Combined Photo-Biomodulation At Acupuncture Points, Autologous PRP, and Umbilical Cord-Derived Exosome Therapy in Autism Spectrum Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-12
SponsorIffat Anwar Medical Complex

About this trial

This randomized controlled trial aims to evaluate the efficacy of a combination of photo-biomodulation at acupuncture points, autologous platelet-rich plasma (PRP), and umbilical cord-derived exosome therapy in children with Autism Spectrum Disorder (ASD). The study will compare these interventions against standard care to determine their impact on the severity of autism symptoms, as measured by the Childhood Autism Rating Scale (CARS) and other related markers.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

• Diagnosis of Autism Spectrum Disorder based on DSM-5 criteria

Age 3-12 years

Stable on current medications for at least 4 weeks prior to study entry

Parents or legal guardians willing to provide informed consent

Disqualifiers

• Severe comorbid medical conditions

Prior stem cell or exosome therapy

History of hypersensitivity to any component of the interventions

Inability to comply with study procedures

Trial design

Design model

Parallel

Treatments tested in this trial

  • Photo-Biomodulation

    Device

    Application at acupuncture points for 20 seconds each week. using 810nm Laser probe

  • Autologous PRP

    Biological/Vaccine

    IV injection of Autologous Plasma Rich Platelets (PRP) on Days 0, 15, 30, and 45.

  • Exosome Therapy

    Biological/Vaccine

    IV injection of Umbilical Cord-Derived Exosomes at laser acupuncture points Umbilical Cord-Derived Exosomes

  • Standard Care (in control arm)

    Other intervention

    Routine conventional including Applied Behavioral Analysis (ABA) for Autism Spectrum Disorder (ASD)

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Control GroupExperimental treatment 1 intervention
Group B: Experimental GroupExperimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

Change in Childhood Autism Rating Scale (CARS) Score (15-60)

Range of CARS Score 15-29.5: Non-autistic. 30-36.5: Mild to moderate autism. 37-60: Severe autism.

Time frame
Baseline
2

Change in Childhood Autism Rating Scale (CARS) Score (15-60)

Range of CARS Score 15-29.5: Non-autistic. 30-36.5: Mild to moderate autism. 37-60: Severe autism.

Time frame
12 Weeks
3

Change in Childhood Autism Rating Scale (CARS) Score (15-60)

Range of CARS Score 15-29.5: Non-autistic. 30-36.5: Mild to moderate autism. 37-60: Severe autism.

Time frame
6 Months
4

Change in Childhood Autism Rating Scale (CARS) Score (15-60)

Range of CARS Score 15-29.5: Non-autistic. 30-36.5: Mild to moderate autism. 37-60: Severe autism.

Time frame
1 Year

Secondary outcomes

1

Assessment of Social Interaction using Autism Diagnostic Observation Schedule (ADOS)

It have 4 modules each module have 28-30 items each item includes rating 0-3 (0 being normal while 3 specifies severe autism)

Time frame
Baseline
2

Assessment of Social Interaction using Autism Diagnostic Observation Schedule (ADOS)

It have 4 modules each module have 28-30 items each item includes rating 0-3 (0 being normal while 3 specifies severe autism)

Time frame
12 Weeks
3

Assessment of Social Interaction using Autism Diagnostic Observation Schedule (ADOS)

It have 4 modules each module have 28-30 items each item includes rating 0-3 (0 being normal while 3 specifies severe autism)

Time frame
6 Months
4

Assessment of Social Interaction using Autism Diagnostic Observation Schedule (ADOS)

It have 4 modules each module have 28-30 items each item includes rating 0-3 (0 being normal while 3 specifies severe autism)

Time frame
1 Year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.